OptimizeRx Corp reports results for the quarter ended September 30 - Earnings Summary

OptimizeRx

14/11/2024 04:16

* OptimizeRx Corp  OPRX.OQ  reported quarterly adjusted
earnings
of 12 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of 9 cents.  The mean expectation of eight analysts
for the quarter was for earnings of 6 cents per share. Wall
Street expected results to range from 1 cents to 10 cents per
share.
    * Revenue rose 30.5% to $21.31 million from a year ago;
analysts
expected $25.00 million. 
    * OptimizeRx Corp's reported EPS for the quarter was a loss
of 50
cents​.
    * The company reported a quarterly loss of $9.12 million.
    * OptimizeRx Corp shares had fallen by 24.4% this
quarter and
lost 59.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the online
services
peer group is also "buy"

Wall Street's median 12-month price target for OptimizeRx Corp
is $11.50 
This summary was machine generated from LSEG data November 14 at
04:16 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.06           0.12           Beat
 Jun. 30 2024      -0.06          0.02           Beat
 Mar. 31 2024      -0.13          -0.11          Beat
 Dec. 31 2023      0.32           0.26           Missed